PharmaCyte Biotech (PMCB) Interest Coverage Ratio (QoQ) (2010 - 2023)
PharmaCyte Biotech (PMCB) Interest Coverage Ratio (QoQ) (2010 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | PharmaCyte Biotech | 4.38 Mn | 4.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2023 | 131.25% |
| Oct 31, 2022 | -132.68% |
| Jan 31, 2022 | -37.83% |
| Oct 31, 2021 | 77.16% |
| Jul 31, 2021 | 83.87% |
| Apr 30, 2021 | -1,872.05% |
| Jan 31, 2021 | -8.93% |
| Oct 31, 2020 | -160.78% |
| Jul 31, 2020 | 95.72% |
| Apr 30, 2019 | 99.76% |
| Apr 30, 2017 | 75.57% |
| Jan 31, 2017 | -257.62% |
| Oct 31, 2016 | -50.97% |
| Jul 31, 2016 | 41.49% |
| Apr 30, 2016 | 78.22% |
| Jan 31, 2016 | -473.88% |
| Oct 31, 2015 | 258.77% |
| Jul 31, 2015 | -106.12% |
| Apr 30, 2015 | -21.15% |
| Jan 31, 2015 | 68.15% |